How long does intramuscular Toradol (ketorolac) last?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Duration of Intramuscular Ketorolac (Toradol)

Intramuscular ketorolac provides analgesic effects lasting approximately 4-6 hours, with peak pain relief occurring 1-2 hours after injection.

Pharmacokinetic Profile

The duration of action for IM ketorolac is determined by its pharmacokinetic properties:

  • Onset of action: Rapid, occurring within 1-2 minutes, with peak plasma concentrations reached in 45-50 minutes 1, 2
  • Peak analgesic effect: Occurs approximately 1-2 hours after intramuscular injection 1
  • Elimination half-life: 4-6 hours in healthy adults 1, 2
  • Duration of analgesic effect: The drug provides pain relief for approximately 4-6 hours based on its half-life and clinical studies 1

Clinical Evidence on Duration

Research comparing IM ketorolac to opioid analgesics demonstrates its prolonged efficacy:

  • Ketorolac (30 mg and 90 mg IM) exhibited significantly longer duration of analgesic effect compared to meperidine, as measured by the percentage of patients requiring additional pain medication 3
  • The onset and peak analgesic effects were equivalent between ketorolac and meperidine, but ketorolac's duration was superior 3

Dosing Schedule Based on Duration

Standard dosing reflects the 4-6 hour duration of action:

  • Initial loading dose: 30-60 mg IM 4
  • Maintenance dosing: 15-30 mg IM every 6 hours 4
  • Maximum duration: Recommended for short-term use (up to 5 days maximum) 4

Important Caveats

The elimination half-life increases in elderly patients and those with renal impairment, which may extend the duration of action but also increases the risk of adverse effects 1. Lower doses (15 mg) are recommended for patients over 65 years, those weighing less than 50 kg, and those with impaired kidney function 4.

The drug is highly protein-bound (>99%) and not extensively distributed outside the vascular compartment, contributing to its predictable duration of action 2.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.